Comparison of Side Effects of the 2015–2016 High-Dose, Inactivated, Trivalent Influenza Vaccine and Standard Dose, Inactivated, Trivalent Influenza Vaccine in Adults ≥65 Years
Sign Up to like & getrecommendations! Published in 2017 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofx001
Abstract: Abstract Background. High-dose, inactivated, trivalent influenza vaccine (HD) is associated with higher rates of side effects than standard dose (SD) vaccine, which may represent a barrier to use. Methods. We surveyed subjects ≥65 years who… read more here.
Keywords: influenza vaccine; trivalent influenza; vaccine; inactivated trivalent ... See more keywords
Inactivated trivalent influenza vaccination is associated with lower mortality among patients with COVID-19 in Brazil
Sign Up to like & getrecommendations! Published in 2020 at "BMJ Evidence-Based Medicine"
DOI: 10.1136/bmjebm-2020-111549
Abstract: Objective To estimate associations between trivalent influenza vaccination and COVID-19 mortality as well as severe clinical outcomes among hospitalised patients. Design Retrospective observational study. Setting This study was conducted among hospitalised patients with COVID-19 in… read more here.
Keywords: mortality; trivalent influenza; patients covid; influenza vaccination ... See more keywords
Quillaja brasiliensis nanoparticle adjuvant formulation improves the efficacy of an inactivated trivalent influenza vaccine in mice
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2023.1163858
Abstract: The threat of viral influenza infections has sparked research efforts to develop vaccines that can induce broadly protective immunity with safe adjuvants that trigger robust immune responses. Here, we demonstrate that subcutaneous or intranasal delivery… read more here.
Keywords: tiv imxqb; influenza vaccine; influenza; quillaja brasiliensis ... See more keywords
A Randomized Controlled Study to Evaluate the Safety and Reactogenicity of a Novel rVLP-Based Plant Virus Nanoparticle Adjuvant Combined with Seasonal Trivalent Influenza Vaccine Following Single Immunization in Healthy Adults 18–50 Years of Age
Sign Up to like & getrecommendations! Published in 2020 at "Vaccines"
DOI: 10.3390/vaccines8030393
Abstract: Inactivated influenza vaccines efficacy is variable and often poor. We conducted a phase 1 trial (NCT02188810), to assess the safety and immunogenicity of a novel nanoparticle Toll-like receptor 7/8 agonist adjuvant (Papaya Mosaic Virus) at… read more here.
Keywords: influenza vaccine; years age; safety; trivalent influenza ... See more keywords